First-in-human study of CDR404, a novel bivalent and bispecific, antibody-derived, T cell engager in MAGE-A4-positive advanced solid cancers
Publication Title
SITC Annual Meeting; November 6-10; Houston, TX. 2024;12(Suppl 2): 628
Document Type
Abstract
Publication Date
11-1-2024
Keywords
oregon; chiles
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
Comments
Spanggaard I, Morotti M, Swiecicki PL, Simonelli M, Montagut GS, Oria de Rueda GDV, Martin-Liberal J, Calvo AH, Kotecki N, Vachtsevanou N, Vrohlings M, Price C, Lenherr-Frey D, Leisner C, Borras L, Bingel-Erlenmeyer R, Biswas S, Prenen H, Curigliano G, Machiels J-P, Lopes G, Diamond M, Leidner RS, Calvo E